@peerhh.bsky.social
Cool! Never thought about this!
December 27, 2024 at 8:39 PM
Cool! Never thought about this!
Renal denervation after simplicity HTN 3
December 16, 2024 at 9:57 PM
Renal denervation after simplicity HTN 3
I‘m pretty sure it‘s a continuum. Full dose with best stroke prevention. But eldercare AF taught us, that „tiny dose doac“ still has a huge effect compared to nothing. www.nejm.org/doi/full/10....
Although off-label, there may be some GP wisdom in it.
Although off-label, there may be some GP wisdom in it.
Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM
Implementation of appropriate oral anticoagulant treatment for the prevention of stroke
in very elderly patients with atrial fibrillation is challenging because of concerns
regarding bleeding. We c...
www.nejm.org
December 16, 2024 at 12:17 PM
I‘m pretty sure it‘s a continuum. Full dose with best stroke prevention. But eldercare AF taught us, that „tiny dose doac“ still has a huge effect compared to nothing. www.nejm.org/doi/full/10....
Although off-label, there may be some GP wisdom in it.
Although off-label, there may be some GP wisdom in it.
Great educational case! The correlation between FFR and resting gradients is ok, but far from perfect (R values ~0,8).
The answer to this case is nicely demonstrated in the paper below: Resting gradients tend to underestimate focal stenosis due to low friction. doi.org/10.1161/CIRC...
The answer to this case is nicely demonstrated in the paper below: Resting gradients tend to underestimate focal stenosis due to low friction. doi.org/10.1161/CIRC...
December 14, 2024 at 8:32 PM
Great educational case! The correlation between FFR and resting gradients is ok, but far from perfect (R values ~0,8).
The answer to this case is nicely demonstrated in the paper below: Resting gradients tend to underestimate focal stenosis due to low friction. doi.org/10.1161/CIRC...
The answer to this case is nicely demonstrated in the paper below: Resting gradients tend to underestimate focal stenosis due to low friction. doi.org/10.1161/CIRC...
I really don‘t like the classification in Type 1/2 MI. It doesn‘t differentiate between demand ischemia and acute coronary obstruction! It differentiales between acute atherothombotic event (T1) and all others (T2). So SCAD and Vasospasm are Type 2 MI although thats clearly not demand ischemia.
December 9, 2024 at 8:49 PM
I really don‘t like the classification in Type 1/2 MI. It doesn‘t differentiate between demand ischemia and acute coronary obstruction! It differentiales between acute atherothombotic event (T1) and all others (T2). So SCAD and Vasospasm are Type 2 MI although thats clearly not demand ischemia.
Or maybe an intranasal diuretic will be the gamechanger: newsroom.heart.org/news/nasal-s...
Nasal spray version of common diuretic has potential to help treat heart failure
Research Highlights: A study testing a new nasal spray form of the medication bumetanide, a commonly prescribed diuretic, was found to be as safe and well-tolerated (meaning with no significant nasal ...
newsroom.heart.org
December 6, 2024 at 1:47 AM
Or maybe an intranasal diuretic will be the gamechanger: newsroom.heart.org/news/nasal-s...
Ich finde das Thema Faktor XI-Inhibition schon spannend. Die Hoffnung wäre, dass dadurch selektiv der intrinsische Gerinnungs-Weg gehemmt wird. Theorie: Thrombus im Vorhofohr wird verhindert, nicht aber Hämostase nach Gefässverletzung. Niedrigere Blutungsneigung wäre dann schon ein Mehrwert.
November 21, 2023 at 8:46 PM
Ich finde das Thema Faktor XI-Inhibition schon spannend. Die Hoffnung wäre, dass dadurch selektiv der intrinsische Gerinnungs-Weg gehemmt wird. Theorie: Thrombus im Vorhofohr wird verhindert, nicht aber Hämostase nach Gefässverletzung. Niedrigere Blutungsneigung wäre dann schon ein Mehrwert.